Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Pediatric Hematology
•
Benign Hematology
•
Thalassemia
How do you counsel patients with transfusion dependent beta thalassemia about luspatercept?
Related Questions
Is there any benefit to using desmopressin over vWF replacement therapy for vWD?
Can lupus anticoagulant be positive despite a normal aPTT?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
For von Willebrand type 2B, do you expect a decline in platelet count over time as vWF increases with age?
What is your recommended long term management of extensive dural venous sinus thrombosis in an otherwise healthy young patient?
How would you approach post-operative VTE prophylaxis for renal transplant in patients with a prior history of provoked VTE?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
In light of the Haven 7 trial results, what considerations should be made regarding the monitoring and management of potential long-term adverse effects of emicizumab in infants?
